Previous Article | Next Article 
Applied and Environmental Microbiology, October 1999, p. 4431-4435, Vol. 65, No. 10
0099-2240/99/$04.00+0
Evaluation of Cryptosporidium parvum
Genotyping Techniques
Irshad M.
Sulaiman,
Lihua
Xiao, and
Altaf A.
Lal*
Division of Parasitic Diseases, National
Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, Georgia 30341
Received 21 December 1998/Accepted 10 July 1999
 |
ABSTRACT |
We evaluated the specificity and sensitivity of 11 previously
described species differentiation and genotyping PCR protocols for
detection of Cryptosporidium parasites. Genomic DNA from
three species of Cryptosporidium parasites (genotype 1 and
genotype 2 of C. parvum, C. muris, and C. serpentis), two Eimeria species (E. neischulzi and E. papillata), and Giardia
duodenalis were used to evaluate the specificity of primers.
Furthermore, the sensitivity of the genotyping primers was tested by
using genomic DNA isolated from known numbers of oocysts obtained from
a genotype 2 C. parvum isolate. PCR amplification was
repeated at least three times with all of the primer pairs. Of the 11 protocols studied, 10 amplified C. parvum genotypes 1 and
2, and the expected fragment sizes were obtained. Our results indicate
that two species-differentiating protocols are not
Cryptosporidium specific, as the primers used in these
protocols also amplified the DNA of Eimeria species. The
sensitivity studies revealed that two nested PCR-restriction fragment
length polymorphism (RFLP) protocols based on the small-subunit rRNA
and dihydrofolate reductase genes are more sensitive than single-round
PCR or PCR-RFLP protocols.
 |
INTRODUCTION |
Cryptosporidium parasites
infect the microvillus border of the gastrointestinal epithelium of a
wide range of vertebrate hosts, including humans. To date, at least 21 Cryptosporidium species have been named (20).
However, only six to eight species (Cryptosporidium parvum,
C. muris, C. wrairi, C. felis,
C. meleagridis, C. baileyi, C. serpentis, and C. nasorum) are considered valid by most
researchers (9, 20). C. parvum is the species
that infects immunocompetent humans and most mammals.
Cross-transmission studies performed with various mammals have
suggested the possibility that zoonotic transmission of C. parvum to humans occurs (13, 20, 24). However,
person-to-person transmission of this parasite has also been
demonstrated (2, 8). In recent years, C. parvum
has been reported to cause waterborne disease outbreaks worldwide (25).
Workers have described many PCR-based protocols for detection of
Cryptosporidium parasites. The primers of these PCR
protocols are based on undefined genomic sequences (14, 18,
29) or specific genes (2, 4, 12, 15). PCR methods have
been shown to be more sensitive and specific than traditional
microscopic techniques for detecting Cryptosporidium spp. in
clinical and environmental samples (16, 19). Recently,
workers have compared the performance of some PCR techniques commonly
used for detection of Cryptosporidium parasites (7, 22,
23).
In recent years, researchers have also developed PCR-based techniques
for differentiating C. parvum of human origin and C. parvum of animal origin. These techniques are based on the
polymorphic nature of C. parvum strains that infect humans
and most animals at the
-tubulin, oocyst wall protein (COWP),
dihydrofolate reductase (DHFR), thrombospondin-related adhesive protein
1 (TRAP-C1), thrombospondin-related adhesive protein 2 (TRAP-C2),
internally transcribed spacer 1 (ITS1), polythreonine repeat (Poly-T),
small-subunit (SSU) rRNA, and undefined genomic sequences (2, 3,
5, 6, 11, 15, 17, 21, 26-28, 30-32). These genotyping tools,
however, were designed to analyze clinical specimens, and the
comparative performance of the protocols has not been evaluated
previously. In this study, we compared eight genotyping protocols
(3, 5, 6, 11, 17, 21, 26-28), two species-differentiating
protocols (2, 15), and one species-differentiating and
genotyping protocol (31) for detecting and differentiating
Cryptosporidium parasites.
 |
MATERIALS AND METHODS |
Oocysts and DNA extraction.
Fecal samples containing
genotype 1 and genotype 2 of C. parvum (based on a DNA
sequence analysis of the TRAP-C2,
-tubulin, and SSU rRNA genes),
C. muris, C. serpentis, Eimeria
neischulzi, E. papillata, and Giardia
duodenalis oocysts were obtained from infected humans and animals
and were stored at 4°C in 2.5% potassium dichromate solutions.
Oocysts and cysts were purified following sucrose and Percoll flotation
(1). Genomic DNA was isolated from the purified oocysts as
described previously (27, 30) and was stored at
20°C
until it was used. The concentrations of DNA samples were determined by
UV absorption at 260 nm.
For sensitivity experiments, genomic DNA was extracted from 500,000, 200,000, 5,000, 1,000, 500, 250, 100, and 50 oocysts of a genotype 2 C. parvum isolate. The DNA was dissolved in 100 µl of
water. Two microliters of each DNA stock preparation was used in the
PCR in order to obtain the equivalent of 10,000, 4,000, 400, 100, 20, 10, 5, 2, and 1 oocysts per PCR mixture.
PCR.
Usually, the PCR mixture contained 50 ng of genomic
DNA, each deoxynucleoside triphosphate (Perkin-Elmer, Foster City,
Calif.) at a concentration of 200 µM, 1× PCR buffer (GeneAmp 10×
PCR buffer; 500 mM KCl, 100 mM Tris-Cl [pH 8.3], 15 mM
MgCl2, 0.01% gelatin; Applied Biosystems, Branchburg,
N.J.), 5.0 U of Taq polymerase (GIBCO BRL, Frederick, Md.),
and the required amounts of forward and reverse primers in a total
volume of 100 µl. The Mg2+ concentration was adjusted by
adding MgCl2. DNA amplification was carried out with a
Perkin-Elmer model PCR 9700 Gene Amp thermocycler for each pair of
primers by using the previously described cycling conditions (initial
hot start, denaturation, annealing, elongation, final extension, and
total number of cycles). A negative control, consisting of a reaction
mixture without the DNA template, was included in each experiment. Each
PCR product was analyzed by electrophoresis in a 1.5% agarose gel and
was visualized after ethidium bromide staining. The same DNA stock
preparation was used as the template in all evaluation experiments.
PCR-RFLP analysis.
Restriction digestion and PCR-restriction
fragment length polymorphism (RFLP) techniques based on Poly-T repeats,
COWP, DHFR, TRAP-C1, TRAP-C2, and the SSU rRNA gene were carried out by
using previously described protocols (6, 11, 26-28, 31).
For the restriction fragment analysis, 20 µl of amplified products
was digested by using 10 U of BpuAI (Boehringer Mannheim,
Indianapolis, Ind.), BstEI (Boehringer), HaeIII
(New England BioLabs, Beverly, Mass.), RsaI (Promega,
Madison, Wis.), SspI (New England BioLabs), or
VspI (GIBCO BRL) and 5 µl of the appropriate restriction
buffer for 1 h under the conditions recommended by the supplier.
The digested products were fractionated by agarose gel electrophoresis and were visualized by ethidium bromide staining.
DNA sequencing and data analysis.
When desired, the
amplified PCR product was purified by using the Wizard PCR Preps DNA
purification system (Promega) and was sequenced with a model ABI 377 automated sequencer by using a dRhodomine terminator cycle sequencing
kit (Applied Biosystems, Foster City, Calif.). A multiple alignment of
the sequences was prepared by using the Genetics Computer Group program
(10).
Nucleotide sequence accession numbers.
The COWP sequences
determined in this study have been deposited in the GenBank database
under accession no. AF161577 to AF161580.
 |
RESULTS |
Genotyping techniques evaluated in the present study.
In the
present study we evaluated 16 primer pairs used for 11 previously
described Cryptosporidium species differentiation and
C. parvum genotyping protocols (Table
1). Of these 11 protocols, 4 are based on
the rRNA gene (2, 5, 15, 31), 2 are based on unknown
sequences (3, 17), and the remainder are based on COWP,
DHFR, TRAP-C1, TRAP-C2, and Poly-T repeats (6, 11, 26-28);
10 of the 11 techniques amplified C. parvum DNA efficiently, and PCR fragments of the expected sizes were produced. The technique of
Bonnin et al. (3) amplified DNA from C. parvum
genotype 2 isolates. However, we were not able to amplify the DNA of
C. parvum genotype 1, C. muris, and C. serpentis isolates under the conditions used in this study. No
amplification was observed even after the Mg2+
concentration was modified and the amount of template was increased or
decreased.
Specificity of Cryptosporidium genotyping tools.
The specificity of the primers was examined by using DNA from three
Cryptosporidium species (genotype 1 and genotype 2 of C. parvum, C. muris, and C. serpentis), two Eimeria species (E. neischulzi and E. papillata), and one
Giardia species (G. duodenalis). The specificity
data are summarized in Table 2. Three SSU
rRNA gene-based protocols were used, and the primers of two of these protocols, those developed by Awad-El-Kariem et al. (2) and Leng et al. (15), amplified the DNA of Eimeria
species in addition to the DNA of Cryptosporidium species,
generating bands of similar sizes (Fig.
1). In contrast, the
Cryptosporidium-specific primers developed by us
(31) produced an ~1,325-bp band during primary PCR and an
~825-bp band during nested PCR from genomic DNA of all
Cryptosporidium species but not from genomic DNA of
Eimeria species or G. duodenalis.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Specificities of previously described
Cryptosporidium species differentiation and C. parvum genotyping protocols
|
|

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 1.
Ethidium bromide-stained gel showing amplification
products obtained from various members of the Apicomplexa by using the
primers of protocols described by Awad-El-Kariem et al. (2)
and Leng et al. (15). Lanes 1 and 9, 100-bp marker; lane 2, C. parvum; lane 3, C. muris; lane 4, C. serpentis; lane 5, G. duodenalis; lane 6, E. neischulzi; lane 7, E. papillata; lane 8, negative
control. (A) Primers of Awad-El-Kariem et al. (2), which
amplified a ~556-bp product. (B) Primers of Leng et al.
(15), which amplified a ~1,750-bp product.
|
|
The PCR-RFLP protocol of Spano et al. (26) was found not to
be C. parvum specific in this study, as it also amplified
genomic DNA of C. muris and C. serpentis. The
COWP gene-based primers did not amplify the DNA of
non-Cryptosporidium parasites but did produce a 550-bp band
with isolates of the two genotypes of C. parvum, C. muris, and C. serpentis. The Poly-T-based PCR-RFLP protocol of Carraway et al. (6), the TRAP-C1-based protocol of Spano et al. (27), the TRAP-C2-based protocol of Sulaiman et al. (28), and the DHFR-based nested PCR-RFLP protocol of Gibbons et al. (11) were found to be C. parvum
specific; the primers used in these protocols amplified only the DNA of
genotype 1 and genotype 2 isolates of C. parvum and did not
amplify the DNA of non-C. parvum parasites.
The two ITS1-based genotype-specific primer sets used in the C. parvum genotyping protocol developed by Carraway et al.
(5) amplified the genomic DNA of genotype 1 and genotype 2 C. parvum isolates. As expected, these primers did not
amplify C. muris, C. serpentis,
Eimeria, and Giardia genomic DNA. The C. parvum-specific randomly amplified polymorphic DNA diagnostic
primers of Morgan et al. (17) produced a 411-bp band with
genotype 1 C. parvum DNA when a human-specific primer was
used and a 311-bp band with genotype 2 C. parvum DNA when
bovine-specific primers were used. These primers did not amplify the
genomic DNA of non-C. parvum parasites in this study.
Evaluation of PCR-RFLP protocols and nucleotide sequencing.
We
also evaluated the restriction digestion procedures used in five
different PCR-RFLP protocols (6, 11, 26-28, 31). The two
species-differentiating protocols of Awad-El-Kariem et al.
(2) and Leng et al. (15) were not evaluated
further due to nonspecific amplification of DNA from other Apicomplexa
species, such as E. neischulzi and E. papillata.
An RFLP analysis of DHFR (11), Poly-T (6),
TRAP-C1 (27), and TRAP-C2 (28) PCR products
showed that the restriction patterns for genotype 1 and genotype 2 of
C. parvum were distinct, as reported in the original papers.
Restriction digestion of SSU rRNA products could be used to
differentiate the Cryptosporidium species, as well as the
two genotypes of C. parvum, as reported previously
(31).
The PCR-amplified COWP products (26) of genotype 1 and
genotype 2 C. parvum and C. muris isolates were
digested with restriction endonuclease RsaI, which resulted
in three distinct band patterns for these isolates (data not shown).
Since the PCR product of a C. serpentis isolate was faint,
it was not subjected to restriction digestion. However, all of the COWP
PCR products were sequenced. A multiple alignment revealed that the
sequences of genotype 1 and genotype 2 C. parvum, C. muris, and C. serpentis isolates were distinct.
Sensitivity of the genotyping primers, as determined by using
genomic DNA extracted from known numbers of oocysts from C. parvum genotype 2 isolates.
Nine PCR protocols were also
evaluated to determine their sensitivity for detecting
Cryptosporidium parasites by using genomic DNA extracted
from known numbers of oocysts of genotype 2 C. parvum isolates. Genotype 2 C. parvum oocysts were used in the
sensitivity experiments because of their abundance. Sensitivity tests
were not performed for the two protocols (2, 15) that were
not specific. Our data on the sensitivity of primers revealed that the
nested PCR protocols of Gibbons et al. (11) and Xiao et al.
(31) were the most sensitive protocols as the two primer pairs amplified the DNA of even a single oocyst. The results of a
comparison of the sensitivities of the genotyping primers are shown in
Table 3.
 |
DISCUSSION |
Results of recent molecular characterization studies have shown
that there are extensive genetic differences among different Cryptosporidium species, as well as within C. parvum. These inter- and intraspecies differences have been used
in the development of molecular diagnostic tools for
Cryptosporidium spp. and for genotype differentiation. So
far, at least two species-specific (2, 15) and seven
genotyping-specific (3, 5, 6, 11, 17, 21, 26-28) protocols
have been described. One PCR-RFLP protocol has been developed for both
species and genotype differentiation (31). Most of these
techniques have not been subjected to evaluation. Recently, several PCR
techniques were evaluated to determine whether they detected C. parvum in environmental samples (7, 22, 23), but most
of the species and genotype differentiation techniques were not
included. The nature of environmental samples suggests that multiple
Cryptosporidium spp. and C. parvum genotypes may be present. Therefore, the species differentiation and C. parvum genotyping techniques should be evaluated before they are
used for analysis of environmental samples.
Two of the three Cryptosporidium species differentiation
techniques based on the SSU rRNA gene were found not to be
Cryptosporidium specific. The primers used in these two
protocols (2, 15) amplified DNA from two Eimeria
species (E. neischulzi and E. papillata). As RFLP
was used for species differentiation and the taxon Apicomplexa contains
thousands of species, the nonspecificity of the two techniques makes
diagnosis of Cryptosporidium species unreliable. The major reason for the nonspecificity is the fact that conserved 18S rRNA sequence data were used when the primers were designed. The primers used by Leng et al. (15) are the universal primers used by
most researchers to clone the SSU rRNA gene of eukaryotic organisms. However, another SSU rRNA-based PCR-RFLP protocol, the protocol of Xiao
et al. (31), was shown to be Cryptosporidium
specific. The primers used in this protocol did not amplify the DNA of
non-Cryptosporidium species. This protocol differentiated
three Cryptosporidium species and two genotypes of C. parvum.
Six C. parvum genotyping protocols, which were based on
DHFR, TRAP-C1, TRAP-C2, ITS1, Poly-T repeats, and an unknown genomic sequence (5, 6, 11, 17, 27, 28), were found to be C. parvum specific. The primers used in these protocols amplified the
DNA of genotype 1 and genotype 2 isolates of C. parvum but not the DNA of non-C. parvum species, Eimeria
spp., or G. duodenalis. In the techniques of Carraway et al.
(5) and Morgan et al. (17) genotype 1- and
genotype 2-specific primers are used. The genotype 1-specific primers
amplify DNA of C. parvum genotype 1 and not DNA of genotype
2 isolates, whereas the genotype 2-specific primers amplify DNA of
C. parvum genotype 2 and not DNA of genotype 1 isolates. Our
studies revealed that these four genotype-specific primers are indeed
C. parvum genotype 1 or genotype 2 specific, as they
amplified and distinguished the two genotypes of C. parvum, as claimed previously. The DHFR-, TRAP-C1-, TRAP-C2-, and Poly-T-based PCR-RFLP techniques (6, 11, 27, 28) were found to be C. parvum specific, and following restriction digestion of
single-round PCR and nested PCR products two distinct band patterns
were obtained for the genotype 1 and genotype 2 C. parvum
isolates. However, a PCR protocol based on an unknown genomic sequence
(3) was shown to be less sensitive, as it amplified only
C. parvum genotype 2 isolates even after the
Mg2+ concentration and the amount of DNA template were modified.
We found that the PCR-RFLP protocol based on the COWP gene
(26) was not C. parvum specific, as the primers
also amplified genomic DNA from other Cryptosporidium spp.
However, the primers did not amplify the DNA of
non-Cryptosporidium parasites. The COWP gene-based PCR-RFLP
protocol has been reported to differentiate C. wrairi (some
workers consider this organism C. parvum) from the two
genotypes of C. parvum (26). We evaluated this
technique by using C. muris and C. serpentis and
identified distinct band patterns for these parasites. Furthermore,
nucleotide sequencing of the PCR products also revealed similar
distinct sequences for different species and genotypes. Therefore, the
set of primers may be utilized for species- and genotype-specific
diagnosis of Cryptosporidium parasites after the primer
sequences are modified.
In summary, the PCR-RFLP protocols of Awad-El-Kariem et al.
(2) and Leng et al. (15) for
Cryptosporidium species differentiation described previously
are not Cryptosporidium specific. We found that the set of
primers developed by Bonnin et al. (3) has poor diagnostic
sensitivity for genotype 1 C. parvum isolates. The PCR-RFLP
method of Spano et al. (26) has the potential to distinguish
different Cryptosporidium species (C. muris and
C. serpentis), as well as the two genotypes of C. parvum. We found that the genotype 1-specific and genotype
2-specific primers of Carraway et al. (5) and Morgan et al.
(17) are C. parvum specific, as these primers
detected C. parvum genotype 1 and genotype 2 isolates.
Similar results were obtained for the DHFR-, TRAP-C1-, TRAP-C2-, and
Poly-T-based PCR-RFLP techniques of Gibbons et al. (11),
Spano et al. (27), Sulaiman et al. (28), and
Carraway et al. (6). The nested PCR-RFLP protocols developed
by Gibbons et al. (11) and Xiao et al. (31) are
the most sensitive protocols evaluated in this study. Additional
evaluations with other apicomplexan parasites and
Cryptosporidium species may be needed before these techniques can be used for analysis of environmental samples.
 |
ACKNOWLEDGMENTS |
This work was supported in part by interagency agreement DW
75937984-01-1 between the U.S. Environmental Protection Agency and the
Centers for Disease Control and Prevention (CDC) and by Opportunistic
Infectious Diseases funds from the CDC.
We thank William P. Shulaw, Bruce Anderson, and Richard J. Montali for
providing Cryptosporidium and Eimeria oocysts and
Giardia cysts.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Parasitic Diseases, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Building 22, Mail Stop F-12, 4770 Buford Highway, Atlanta, GA 30341-3717. Phone: (770) 488-4047. Fax:
(770) 488-4454. E-mail: AAL1{at}CDC.GOV.
 |
REFERENCES |
| 1.
|
Arrowood, M. J., and C. R. Sterling.
1987.
Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.
J. Parasitol.
73:314-319[Medline].
|
| 2.
|
Awad-El-Kariem, F. M.,
D. C. Warhurst, and V. McDonald.
1994.
Detection of Cryptosporidium oocysts using a system based on PCR and endonuclease restriction.
Parasitology
109:19-22.
|
| 3.
|
Bonnin, A.,
M. N. Fourmaux,
J. F. Dubremetz,
R. G. Nelson,
P. Gobet,
G. Harly,
M. Buisson,
D. Puygauthier-Toubas,
F. Gabriel-Pospisil,
M. Naciri, and P. Camerlynch.
1996.
Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence.
FEMS Microbiol. Lett.
137:207-211[Medline].
|
| 4.
|
Cai, J.,
M. D. Collins,
V. McDonald, and D. E. Thompson.
1992.
PCR cloning and nucleotide sequence determination of the 18S rRNA genes and internal transcribed spacer 1 of the protozoan parasites Cryptosporidium parvum and Cryptosporidium muris.
Biochim. Biophys. Acta
1131:317-320[Medline].
|
| 5.
|
Carraway, M.,
S. Tzipori, and G. Widmer.
1996.
Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat.
Appl. Environ. Microbiol.
62:712-716[Abstract].
|
| 6.
|
Carraway, M.,
S. Tzipori, and G. Widmer.
1997.
A new restriction fragment length polymorphism from Cryptosporidium parvum identifies genetically heterogeneous parasite populations and genotypic changes following transmission from bovine to human hosts.
Infect. Immun.
65:3958-3960[Abstract].
|
| 7.
|
Champliaud, D.,
P. Gobet,
M. Naciri,
O. Vagner,
J. Lopez,
J. C. Buisson,
I. Varga,
G. Harly,
R. Mancassola, and A. Bonnin.
1998.
Failure to differentiate Cryptosporidium parvum from C. meleagridis based on PCR amplification of eight DNA sequences.
Appl. Environ. Microbiol.
64:1454-1458[Abstract/Free Full Text].
|
| 8.
|
Cordell, R. L., and D. G. Addiss.
1994.
Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control.
Pediatr. Infect. Dis. J.
13:311-317.
|
| 9.
|
Fayer, R.,
C. A. Speer, and J. P. Dubey.
1997.
The general biology of Cryptosporidium, p. 1-41.
In
R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
|
| 10.
|
Genetics Computer Group.
1996.
Wisconsin package, version 9.0.
Genetics Computer Group, Madison, Wis.
|
| 11.
|
Gibbons, C. L.,
B. G. Gazzard,
M. Ibrahim,
S. Morris-Jones,
C. S. L. Ong, and F. M. Awad-El-Kariem.
1998.
Correlation between markers of strain variation in Cryptosporidium parvum: evidence of clonality.
Parasitol. Int.
47:139-147.
|
| 12.
|
Johnson, D. W.,
N. J. Pienaiazek,
D. W. Griffin,
L. Misener, and J. B. Rose.
1995.
Development of a PCR protocol for sensitive detection of Cryptosporidium oocysts in water samples.
Appl. Environ. Microbiol.
61:3849-3855[Abstract].
|
| 13.
|
Laberge, I.,
A. Ibrahim,
J. R. Barta, and M. W. Griffiths.
1996.
Detection of Cryptosporidium parvum in raw milk by PCR and oligonucleotide probe hybridization.
Appl. Environ. Microbiol.
62:3259-3264[Abstract].
|
| 14.
|
Laxer, M. A.,
B. K. Timblin, and R. J. Patel.
1991.
DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction.
Am. J. Trop. Med. Hyg.
45:688-694.
|
| 15.
|
Leng, X.,
D. A. Mosier, and R. D. Oberst.
1996.
Differentiation of Cryptosporidium parvum, C. muris, and C. baileyi by PCR-RFLP analysis of the 18S rRNA gene.
Vet. Parasitol.
62:1-7[Medline].
|
| 16.
|
Mayer, C. L., and C. J. Palmer.
1996.
Evaluation of PCR, nested PCR, and fluorescent antibodies for detection of Giardia and Cryptosporidium species in wastewater.
Appl. Environ. Microbiol.
62:2081-2085[Abstract].
|
| 17.
|
Morgan, U. M.,
C. Clare,
C. C. Constantine,
D. A. Forbes, and R. C. A. Thompson.
1997.
Differentiation between human and animal isolates of Cryptosporidium parvum using rDNA sequencing and direct PCR analysis.
J. Parasitol.
83:825-830[Medline].
|
| 18.
|
Morgan, U. M.,
P. A. O'Brien, and R. C. A. Thompson.
1996.
The development of diagnostic PCR primers for Cryptosporidium using RAPD-PCR.
Mol. Biochem. Parasitol.
77:103-108[Medline].
|
| 19.
|
Morgan, U. M.,
L. Pallant,
B. W. Dwyer,
D. A. Forbes,
G. Rich, and R. C. A. Thompson.
1998.
Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial.
J. Clin. Microbiol.
36:995-998[Abstract/Free Full Text].
|
| 20.
|
O'Donoghue, P. J.
1995.
Cryptosporidium and cryptosporidiosis in man and animals.
Int. J. Parasitol.
25:139-195[Medline].
|
| 21.
|
Peng, M. P.,
L. Xiao,
A. R. Freeman,
M. J. Arrowood,
A. Escalante,
A. C. Weltman,
C. S. L. Ong,
W. R. MacKenzie,
A. A. Lal, and C. B. Beard.
1997.
Genetic polymorphism among Cryptosporidium parvum isolates supporting two distinct transmission cycle.
Emerg. Infect. Dis.
3:1-9[Medline].
|
| 22.
|
Rochelle, P. A.,
R. D. Leon,
M. H. Stewart, and R. L. Wolf.
1997.
Comparisons of primers and optimization of PCR conditions for detection of Cryptosporidium parvum and Giardia lamblia in water.
Appl. Environ. Microbiol.
63:106-114[Abstract].
|
| 23.
|
Sluter, S. D.,
S. Tzipori, and G. Widmer.
1997.
Parameters affecting polymerase chain reaction detection of waterborne Cryptosporidium parvum oocysts.
Appl. Microbiol. Biotechnol.
48:325-330[Medline].
|
| 24.
|
Smith, H. V.
1990.
Environmental aspects of Cryptosporidium species: a review.
J. R. Soc. Med.
83:629-631[Medline].
|
| 25.
|
Smith, H. V., and J. B. Rose.
1998.
Water borne cryptosporidiosis: current status.
Parasitol. Today
14:14-22.
|
| 26.
|
Spano, F.,
L. Putignani,
J. McLauchlin,
D. P. Casemore, and A. Crisanti.
1997.
PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin.
FEMS Microbiol. Lett.
150:209-217[Medline].
|
| 27.
|
Spano, F.,
L. Putignani,
S. Guida, and A. Crisanti.
1998.
Cryptosporidium parvum: PCR-RFLP analysis of the TRAP-C1 (thrombospondin-related adhesive protein of Cryptosporidium-1) gene discriminates between two alleles differentially associated with parasite isolates of animal and human origin.
Exp. Parasitol.
90:195-198[Medline].
|
| 28.
|
Sulaiman, I. M.,
L. Xiao,
C. Yang,
L. Escalante,
A. Moore,
C. B. Beard,
M. J. Arrowood, and A. A. Lal.
1998.
Differentiating human from animal isolates of Cryptosporidium parvum.
Emerg. Infect. Dis.
4:681-685[Medline].
|
| 29.
|
Sulaiman, I. M.,
L. Xiao,
M. J. Arrowood, and A. A. Lal.
1999.
Biallelic polymorphism in the intron region of -tubulin gene of Cryptosporidium parasites.
J. Parasitol.
85:154-157[Medline].
|
| 30.
|
Webster, K. A.,
J. D. E. Pow,
M. Giles,
J. Catchpole, and M. J. Woodward.
1993.
Detection of Cryptosporidium parvum using specific polymerse chain reaction.
Vet. Parasitol.
50:35-44[Medline].
|
| 31.
|
Xiao, L.,
L. Escalante,
C. Yang,
I. Sulaiman,
A. A. Escalante,
R. J. Montali,
R. Fayer, and A. A. Lal.
1999.
Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus.
Appl. Environ. Microbiol.
65:1578-1583[Abstract/Free Full Text].
|
| 32.
|
Xiao, L.,
I. M. Sulaiman,
R. Fayer, and A. A. Lal.
1998.
Species and strain-specific typing of Cryptosporidium parasites in clinical and environmental samples.
Mem. Inst. Oswaldo Cruz, Rio de J.
93:687-692.
|
Applied and Environmental Microbiology, October 1999, p. 4431-4435, Vol. 65, No. 10
0099-2240/99/$04.00+0
This article has been cited by other articles:
-
Ruecker, N. J., Bounsombath, N., Wallis, P., Ong, C. S. L., Isaac-Renton, J. L., Neumann, N. F.
(2005). Molecular Forensic Profiling of Cryptosporidium Species and Genotypes in Raw Water. Appl. Environ. Microbiol.
71: 8991-8994
[Abstract]
[Full Text]
-
Nichols, R. A. B., Campbell, B. M., Smith, H. V.
(2003). Identification of Cryptosporidium spp. Oocysts in United Kingdom Noncarbonated Natural Mineral Waters and Drinking Waters by Using a Modified Nested PCR-Restriction Fragment Length Polymorphism Assay. Appl. Environ. Microbiol.
69: 4183-4189
[Abstract]
[Full Text]
-
LeChevallier, M. W., Di Giovanni, G. D., Clancy, J. L., Bukhari, Z., Bukhari, S., Rosen, J. S., Sobrinho, J., Frey, M. M.
(2003). Comparison of Method 1623 and Cell Culture-PCR for Detection of Cryptosporidium spp. in Source Waters. Appl. Environ. Microbiol.
69: 971-979
[Abstract]
[Full Text]
-
Tanriverdi, S., Tanyeli, A., Baslamisli, F., Koksal, F., Kilinc, Y., Feng, X., Batzer, G., Tzipori, S., Widmer, G.
(2002). Detection and Genotyping of Oocysts of Cryptosporidium parvum by Real-Time PCR and Melting Curve Analysis. J. Clin. Microbiol.
40: 3237-3244
[Abstract]
[Full Text]
-
Elwin, K., Chalmers, R. M., Roberts, R., Guy, E. C., Casemore, D. P.
(2001). Modification of a Rapid Method for the Identification of Gene-Specific Polymorphisms in Cryptosporidiumparvum and Its Application to Clinical and Epidemiological Investigations. Appl. Environ. Microbiol.
67: 5581-5584
[Abstract]
[Full Text]
-
Sturbaum, G. D., Reed, C., Hoover, P. J., Jost, B. H., Marshall, M. M., Sterling, C. R.
(2001). Species-Specific, Nested PCR-Restriction Fragment Length Polymorphism Detection of Single Cryptosporidium parvum Oocysts. Appl. Environ. Microbiol.
67: 2665-2668
[Abstract]
[Full Text]
-
Xiao, L., Alderisio, K., Limor, J., Royer, M., Lal, A. A.
(2000). Identification of Species and Sources of Cryptosporidium Oocysts in Storm Waters with a Small-Subunit rRNA-Based Diagnostic and Genotyping Tool. Appl. Environ. Microbiol.
66: 5492-5498
[Abstract]
[Full Text]
-
Xiao, L., Limor, J., Morgan, U. M., Sulaiman, I. M., Thompson, R. C. A., Lal, A. A.
(2000). Sequence Differences in the Diagnostic Target Region of the Oocyst Wall Protein Gene of Cryptosporidium Parasites. Appl. Environ. Microbiol.
66: 5499-5502
[Abstract]
[Full Text]
-
McLauchlin, J., Amar, C., Pedraza-Díaz, S., Nichols, G. L.
(2000). Molecular Epidemiological Analysis of Cryptosporidium spp. in the United Kingdom: Results of Genotyping Cryptosporidium spp. in 1,705 Fecal Samples from Humans and 105 Fecal Samples from Livestock Animals. J. Clin. Microbiol.
38: 3984-3990
[Abstract]
[Full Text]